RGNX – REGENXBIO Inc.
RGNX
$8.39Name : REGENXBIO Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $422,761,216.00
EPSttm : -3.09
REGENXBIO Inc.
$8.39
Float Short %
12.07
Margin Of Safety %
Put/Call OI Ratio
0.53
EPS Next Q Diff
0.96
EPS Last/This Y
4.82
EPS This/Next Y
-1.75
Price
8.38
Target Price
33.15
Analyst Recom
1.38
Performance Q
6.07
Relative Volume
1.03
Beta
1.08
Ticker: RGNX
19 items
«
‹
of 1
›
»
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
---|---|---|---|---|---|
2025-06-02 | RGNX | 10.33 | 0.35 | 0.03 | 4238 |
2025-06-03 | RGNX | 10.14 | 0.34 | 0.06 | 4391 |
2025-06-04 | RGNX | 10.09 | 0.34 | 0.00 | 4459 |
2025-06-05 | RGNX | 8.36 | 0.34 | 0.42 | 4434 |
2025-06-06 | RGNX | 9.59 | 0.34 | 0.02 | 4794 |
2025-06-09 | RGNX | 9.51 | 0.29 | 0.18 | 5347 |
2025-06-10 | RGNX | 9.81 | 0.29 | 0.01 | 5408 |
2025-06-11 | RGNX | 10.2 | 0.27 | 0.00 | 5626 |
2025-06-12 | RGNX | 10.22 | 0.28 | 0.00 | 5605 |
2025-06-13 | RGNX | 9.26 | 0.27 | 0.48 | 5605 |
2025-06-16 | RGNX | 9.16 | 0.28 | 0.03 | 5665 |
2025-06-17 | RGNX | 8.64 | 0.30 | 0.01 | 5496 |
2025-06-18 | RGNX | 8.55 | 0.30 | 0.10 | 5458 |
2025-06-20 | RGNX | 8.43 | 0.30 | 4.67 | 5510 |
2025-06-23 | RGNX | 7.84 | 0.44 | 25.14 | 3779 |
2025-06-24 | RGNX | 8.57 | 0.48 | 0.04 | 3913 |
2025-06-25 | RGNX | 8.54 | 0.47 | 17.33 | 4007 |
2025-06-26 | RGNX | 8.76 | 0.54 | 0.00 | 4216 |
2025-06-27 | RGNX | 8.38 | 0.53 | 3.09 | 4239 |
Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
---|---|---|---|---|---|
2025-06-02 | RGNX | 10.35 | -0.4 | 246.1 | 0.23 |
2025-06-03 | RGNX | 10.13 | -0.4 | 219.2 | 0.23 |
2025-06-04 | RGNX | 10.09 | -0.4 | 221.4 | 0.23 |
2025-06-05 | RGNX | 8.36 | -0.4 | 199.2 | 0.23 |
2025-06-06 | RGNX | 9.60 | -0.4 | 244.8 | 0.23 |
2025-06-09 | RGNX | 9.53 | -0.4 | 220.9 | 0.23 |
2025-06-10 | RGNX | 9.81 | -0.4 | 226.0 | 0.23 |
2025-06-11 | RGNX | 10.21 | -0.4 | 227.5 | 0.23 |
2025-06-12 | RGNX | 10.20 | -0.4 | 222.0 | 0.23 |
2025-06-13 | RGNX | 9.26 | -0.4 | 209.7 | 0.23 |
2025-06-16 | RGNX | 9.17 | -0.4 | 220.2 | 0.23 |
2025-06-17 | RGNX | 8.64 | -0.4 | 213.8 | 0.23 |
2025-06-18 | RGNX | 8.57 | -0.4 | 220.4 | 0.23 |
2025-06-20 | RGNX | 8.43 | -0.4 | 219.3 | 0.23 |
2025-06-23 | RGNX | 7.85 | -0.4 | 211.4 | 0.23 |
2025-06-24 | RGNX | 8.56 | -0.4 | 236.2 | 0.23 |
2025-06-25 | RGNX | 8.53 | -0.4 | 221.4 | 0.23 |
2025-06-26 | RGNX | 8.77 | -0.4 | 226.1 | 0.23 |
2025-06-27 | RGNX | 8.38 | -0.4 | 215.6 | 0.23 |
Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
19 items
«
‹
Current Page1 of 1
›
»
19 items
«
‹
of 1
›
»
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
---|---|---|---|---|
2025-06-02 | RGNX | -0.44 | 2.31 | 13.85 |
2025-06-03 | RGNX | -0.44 | 2.31 | 13.85 |
2025-06-04 | RGNX | -0.44 | 2.31 | 13.85 |
2025-06-05 | RGNX | -0.44 | 2.31 | 13.85 |
2025-06-06 | RGNX | -0.44 | 2.31 | 13.85 |
2025-06-09 | RGNX | -0.44 | 2.33 | 13.87 |
2025-06-10 | RGNX | -0.44 | 2.33 | 13.87 |
2025-06-11 | RGNX | -0.44 | 2.33 | 13.25 |
2025-06-12 | RGNX | -0.44 | 2.33 | 13.25 |
2025-06-13 | RGNX | -0.44 | 2.33 | 13.25 |
2025-06-16 | RGNX | -0.44 | 2.34 | 13.25 |
2025-06-17 | RGNX | -0.44 | 2.34 | 13.25 |
2025-06-18 | RGNX | -0.43 | 2.34 | 13.19 |
2025-06-20 | RGNX | -0.43 | 2.34 | 13.19 |
2025-06-23 | RGNX | -0.43 | 2.34 | 13.19 |
2025-06-24 | RGNX | -0.43 | 2.34 | 13.19 |
2025-06-25 | RGNX | -0.43 | 2.34 | 13.19 |
2025-06-26 | RGNX | -0.43 | 2.34 | 12.07 |
2025-06-27 | RGNX | -0.43 | 2.34 | 12.07 |
Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
19 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
0.12
Avg. EPS Est. Current Quarter
-1.05
Avg. EPS Est. Next Quarter
1.08
Insider Transactions
-0.43
Institutional Transactions
2.34
Beta
1.08
Average Sales Estimate Current Quarter
40
Average Sales Estimate Next Quarter
110
Fair Value
Quality Score
44
Growth Score
34
Sentiment Score
34
Actual DrawDown %
83.3
Max Drawdown 5-Year %
-89.4
Target Price
33.15
P/E
Forward P/E
PEG
P/S
2.7
P/B
1.53
P/Free Cash Flow
EPS
-3.14
Average EPS Est. Cur. Y
0.23
EPS Next Y. (Est.)
-1.52
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-100.62
Relative Volume
1.03
Return on Equity vs Sector %
-81.4
Return on Equity vs Industry %
-63.6
EPS 1 7Days Diff
EPS 1 30Days Diff
1.21
EBIT Estimation
215.6
Sector: Healthcare
Industry: Biotechnology
Employees: 353
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapies that deliver functional genes to cells with genetic defects in the United States. Its gene therapy product candidates are based on NAV Technology Platform, a proprietary adeno-associated virus gene delivery platform. The company's products in pipeline includes ABBV-RGX-314 for the treatment of wet age-related macular degeneration, diabetic retinopathy, and other chronic retinal diseases; and RGX-202, which is in Phase III clinical trial for the treatment of Duchenne muscular dystrophy, as well as RGX-121 for the treatment of mucopolysaccharidosis type II. It also develops RGX-111 for the treatment of mucopolysaccharidosis type I, RGX-181 for the treatment of late-infantile neuronal ceroid lipofuscinosis type 2, and RGX-381 for the treatment of the ocular manifestations of CLN2 disease. In addition, the company licenses its NAV Technology Platform to other biotechnology and pharmaceutical companies. Further, it has a collaboration and license agreement with AbbVie Global Enterprises Ltd. to develop ABBV-RGX-314 outside the United States. REGENXBIO Inc. was incorporated in 2008 and is headquartered in Rockville, Maryland.
stock quote shares RGNX – REGENXBIO Inc. Stock Price stock today
news today RGNX – REGENXBIO Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RGNX – REGENXBIO Inc. yahoo finance google finance
stock history RGNX – REGENXBIO Inc. invest stock market
stock prices RGNX premarket after hours
ticker RGNX fair value insiders trading